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Background and Objective. The relationship between
cytokine concentrations and transplant-related com-
plications has been studied in bone marrow trans-
plant patients. The changes in TNF-a, IL-1 and IL-6
concentrations after transplantation are well docu-
mented in the literature but this is not the case for
IL-8. The purpose of the present study was to inves-
tigate prospectively the plasma concentration of
these cytokines and their relationship to transplant-
related complications.
Design and Methods. Pro-inflammatory cytokine
(TNF-a, IL-1, IL-6 and IL-8) levels in plasma were
determined in a group of 53 patients undergoing
hematopoietic progenitor transplantation. Plasma
samples were collected weekly from day –7 to day
+35 and stored at –70 ºC until assayed by ELISA.
The major transplant-related toxicities registered
were: veno-occlusive disease (VOD), acute graft-ver-
sus-host disease (GVHD), infectious  episodes, renal
failure and mucositis.
Results. In spite of the great variability of plasma
cytokine profiles between the different patients, we
came to various conclusions. Patients’ TNF-a and IL-
1 concentrations correlated well over time. IL-6 and IL-
8 profiles were similar and correlated well with febrile
episodes. In some cases, an increase in IL-6 preced-
ed hematologic recovery. In our study, increased lev-
els of TNF-a, IL-6 and especially IL-8 correlated with
hepatic or renal dysfunction as evaluated by increased
bilirubin and creatinine in plasma, while pulmonary
complications correlated only with increased IL-6 lev-
els. Allogeneic transplant patients had a tendency to
have higher TNF-a concentrations than autologous
transplant patients, probably because an allogeneic
transplant is associated with more transplant-related
toxicity. Basal disease usually had no effect on
cytokine profiles.
Interpretation and Conclusions. IL-6 and IL-8 were
the only cytokines studied whose increase correlat-
ed with febrile episodes. High IL-8 values may be a
useful predictor of renal dysfunction and pulmonary
disease and seems to trigger off high IL-6 levels. Plas-
ma TNF-a and IL-1 concentrations during the post-
transplant period have not been shown to be predic-
tive of the development of transplant-related compli-
cations, and none of the profiles was recognized to
be specific for a particular complication in this study. 
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Cytokines are low molecular weight glycopro-teins involved in inflammatory and immuneresponses. Some cytokines have a stimulato-
ry effect on hematopoiesis and behave as growth fac-
tors.1 They are predominantly produced by lympho-
cytes and mononuclear phagocytes and stimulate or
suppress different kinds of inflammatory responses
interacting within a complicated network.
The dysregulation of cytokine production seems
to be involved in the rejection or tolerance of grafts,2
and in the initiation and perpetuation of tissue dam-
age in bone marrow and solid organ transplants.3
Tumor necrosis factor-a (TNF-a), interleukin-1
(IL-1), interleukin-6 (IL-6) and interleukin-8 (IL-8)
are well known pro-inflammatory cytokines involved
in local and systemic inflammatory reactions. This
fact has been found to be especially important in
endotoxemia.4,5 TNF-a, IL-1, IL-6 and IL-8 are also
involved in many adverse conditions proceeding
from a hematopoietic progenitor transplant such as
infections, mucositis,  hepatic veno-occlusive disease
(VOD) and graft-versus-host disease (GvHD). TNF-
a, IL-1 and IL-6  levels after transplantation have
been widely determined, but IL-8 levels less so. A
detailed comparison of cytokine plasma levels
showed a very high variability that hindered further
analysis.6-10
We studied the relationship between plasma con-
centrations of pro-inflammatory cytokines (TNF-a,
IL-1, IL-6 and IL-8) and transplant-related compli-
cations in a group of 53 patients undergoing hema-
topoietic progenitor transplant, in order to clarify
the behavior of these cytokines after a bone marrow




We studied 53 patients with a hematologic malig-
nancy undergoing a bone marrow (BM) or peripheral
blood stem cell (PBSC) transplant between September
1993 and March 1995 in our center.
Blood sample collection
Blood samples were collected in tubes containing
EDTA and sodium citrate, on days -7, -1, +1, +7, +14,
+21, +28 and +35 and stopped when hematologic
recovery was established. Samples were placed on
ice, centrifuged within 2 hours of blood collection,
and then transferred to microfuge tubes and frozen
at –70ºC until assayed.
Definition of major transplant-related
complications
The diagnosis of hepatic VOD required the pres-
ence of hyperbilirubinemia (>3.0 mg/dL), weight gain
(>2.5% of initial weight) and right upper quadrant
pain with or without the presence of hepatomegaly.11
GvHD was evaluated following  the updated acute
GvHD grading system proposed by Przepiorka et al.12
Severity of mucositis was scored in accordance with
previously  published criteria.13
Determination of TNF-a, IL-1, IL-6 and IL-8 levels
TNF-a, IL-1, IL-6 and IL-8 plasma levels were deter-
mined by a double antibody sandwich ELISA (Immu-
notech International, Montpellier, France), follow-
ing the manufacturer’s instructions. Briefly, calibra-
tion standards were prepared by dilution of a stock
solution of cytokine and a monoclonal anti-cytokine
capture antibody was attached to the surface of the
wells of a microtiter plate. Standard or serum sam-
ples were added to the wells and incubated with an
anti-cytokine monoclonal antibody conjugated to
alkaline phosphatase. Finally, after the incubation
and washing steps, the substrate was added to each
well. The reaction was stopped with NaOH and the
absorbance of the wells was measured at 450 nm.
Cytokine concentrations in the test samples were
determined by comparison with the standard curve
obtained from the controls.
Statistical analysis
The correlations between numerical variables were
assessed using the Spearman rank test. The Wilcox-
on signed rank test was also used when variables did
not follow a normal distribution. Differences were
considered statistically significant when p<0.05.
Results
Patients’ description
Patients’ characteristics, conditioning therapy, and
graft-versus-host disease prophylactic regimens are
described in Table 1. 
The average age of the patients studied was 32.4
years (range: 15-59). Of the 53 patients, 27 (51%) had
allogeneic transplants and the other 26 (49%) had an
autologous transplant of peripheral blood or bone
marrow stem cells. Most of the patients suffered from
acute (23 patients) or chronic (14 patients) leukemia.
The most frequently used conditioning therapy con-
sisted of cyclophosphamide and total body irradia-
tion (TBI).
Plasma cytokine concentrations
TNF-a, IL-1, IL-6 and IL-8 concentrations were
determined in 270 plasma samples from 53 patients
undergoing hematopoietic transplantation and are
shown in Figure 1.
The plasma profiles of the four cytokines showed
a great variability between the different patients.
Plasma levels of TNF-a and IL-1 on day -7 showed
a strong positive correlation with the subsequent con-
centrations of TNF and IL-1 respectively. Patients with
high TNF-a and IL-1 levels at the beginning of the
transplantation retained these high levels throughout
the procedure. This correlation was not observed as
clearly for IL-6 and IL-8 (data not shown).
The correlation coefficients between IL-6 and IL-8
reached statistical significance on the same day of
measurement for days +1 (r=0.46, p<0.05), +7
(r=0.64, p<0.005), +14 (r=0.62, p<0.005), +21
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Table 1. Description of patients’ characteristics, condi-





allogeneic BM 27 (51%)
autologous BM 16 (30%)














CsA + MTX + PDN + T cell depletion 11 (41%)
CsA + MTX + PDN 9 (33%)
CsA + MTX 5 (19%)
CSA + MTX + T cell depletion 2 (7%)
*Only for allogeneic transplants (27 patients).
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(r=0.49, p<0.005) and +28 (r=0.36, p<0.1). The pro-
file of both cytokines was very similar in each patient.
Relationship between plasma cytokine levels
and transplant-related complications
High plasma TNF-a concentrations seem to pre-
dict the severity of the mucositis after transplanta-
tion from very early stages, i.e. days –1 (r=0.46,
p<0.026), +14 (r=0.29, p<0.041) and +21 (r=0.39,
p<0.033). The same positive correlation was also
observed between mucositis and IL-6 plasma levels
on days –1 (r=0.39, p<0.07), +1 (r=0.42, p<0.043)
and +14 (r=0.34, p<0.028).
No clear correlation was detected between mucosi-
tis and IL-1 or IL-8 plasma concentrations. Figure 2
shows the evolution of the four cytokine levels
throughout the study period in two patients, one who
suffered from fever, and one who did not.
IL-6 and IL-8 profiles proved to be good indicators
of febrile episodes. In all the patients with a febrile
episode the mean plasma cytokine levels determined
on the first day studied before and after the first
febrile episode showed a significant increase in IL-6
and IL-8 concentrations (Table 2). This was not
observed for TNF-a or IL-1. Although not statistical-
ly significant, IL-6 levels tended to be higher in the
patients who died of infection than in those who died
of acute graft-versus-host disease (data not shown).
In 4 out of 6 patients with no febrile episodes dur-
ing the transplantation period, IL-6 and IL-8 con-
centration peaks preceded the granulocyte recovery
(Figure 2).
There was a positive correlation between IL-6 and
IL-8 levels, and bilirubin values on the same days. IL-
6 and bilirubin positively correlated on days +7
(r=0.26, p<0.1), +21 (r=0.41, p<0.1) and +28
(r=0.38, p<0.05). A stronger correlation was estab-
lished between IL-8 and bilirubin levels on days +7
(r=0.47, p<0.05), +14 (r=0.31, p<0.05), +21 (r=0.37,
p< 0.05) and +28 (r=0.072, p<0.005). Although the
correlation coefficients are not very high, elevated lev-
els of IL-6 and IL-8 preceding the transplant seem to
predict renal dysfunction (Table 3).  The only cytokine
that showed a relationship with the onset of pul-
monary complications (pneumonia or pulmonary
hemorrhage) was IL-6, as the plasma levels of this
cytokine were higher on days –7 (70.9±3.8 pg/mL vs.
50.6±43.6 pg/mL, p<0.069), –1 (84.6±22.0 pg/mL vs.
37.5±43.4 pg/mL, p<0.048), +14 (276.9±362.8
pg/mL vs. 88.5±100.2 pg/mL, p<0.260) and +21
(213.3±226.2 pg/mL vs. 85.5±114.5 pg/mL, p<0.092)
of the transplantation in patients with these compli-
cations. No relationship between the different cyto-
kines and the onset or severity of acute GvHD  was
observed in our data (not shown).
Relationship between plasma cytokine levels
and basal disease or kind of transplant
Basal disease did not show an important effect on
cytokine profiles.
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Figure 1.
Table 2.  Mean plasma cytokine concentrations determined
on the first day studied  before (BF) and after (AF) the first
febrile episode (SD=standard deviation).
Mean SD Minimum Maximum
TNF (BF) 51.86 32.27 13.2 145.6
TNF (AF) 48.94 30.78 14.4 165.4 t=0.15, 
p=0.878
IL-1 (BF) 17.04 41.40 0 203.9
IL-1 (AF) 13.35 23.40 0 121 t=0.06, 
p=0.955
IL-6 (BF) 66.91 71.01 0 370
IL-6 (AF) 140.54 133 11.8 520 t=3.34, 
p=0.002
IL-8 (BF) 11.18 12.3 0 49.5


















Plasma TNF-a concentrations were higher in
patients undergoing an allogeneic transplant than in
those receiving an autologous hematopoietic progen-
itor transplant. This was particularly noticeable on
days +1 (59.6±40.3 pg/mL vs. 39.2±18.0 pg/mL,
p<0.114), +14 (58.0±25.8 pg/mL vs. 46.0±19.5
pg/mL, p<0.080) and +21 (60.3±24.3 pg/mL vs.
46.7±21.5 pg/mL, p<0.068). No differences in the
plasma levels of IL-1, IL-6 or IL-8 according to by the
different basal diseases or the type of transplant were
detected.
Discussion
Plasma TNF-a, IL-1, IL-6 and IL-8 levels were stud-
ied in a group of 53 patients undergoing a bone mar-
row or peripheral blood stem cell transplant.
A strong correlation between IL-6 and IL-8 levels in
plasma was observed in this study throughout the
study period. IL-6 and IL-8 profiles correlated well
with febrile episodes in this study, with higher levels
of IL-6 in the plasma of patients who died of infec-
tion than in those who died of acute GvHD. Cyto-
kines were also related to the hematologic recovery.
The levels of TNF-a, IL-1 and IL-6 in plasma or
serum after a hematopoietic transplant have been
reported by many groups,6,8,14-18 but little attention
has been paid to IL-8 detection.9,10
According to some authors, patients experiencing
major organ toxicity after a transplant such as infec-
tion, endothelial leakage syndrome, veno-occlusive
disease, GvHD or pneumonia, are supposed to have
higher TNF-a levels than those patients without
major organ toxicities.7,14 Other authors, including
those of the present study, have not observed this
relationship.8,15
TNF-a and IL-1 are known inducers of IL-6 and IL-
8 production, while IL-6 is a strong inhibitor of TNF-
a and IL-1, and due to this negative feed-back, IL-6
is a factor which limits hyperactivation of the proin-
flammatory cytokine cascade.19 IL-6 has no stimula-
tory effect on IL-8, therefore, probably the same
agents are stimulating IL-6 and IL-8 production in
parallel. However, we detected a positive correlation
between plasma concentrations of TNF-a and IL-6
and severity of mucositis, a correlation which was not
observed for IL-8.
Intravenous administration of endotoxin to healthy
human volunteers causes an increase in TNF-a, IL-6
and IL-8 plasma levels.4,20 In non-hematologic
patients admitted to an intensive care unit, IL-6 and
IL-8 plasma levels were higher in septic patients.21
Many studies have pointed out a strong correlation
between IL-6 and/or IL-8 concentrations and the
onset of infectious complications in patients with
hematologic malignancies and chemotherapy-induc-
ed leukocytopenia.5,8,22-24 The same finding has been
confirmed in patients undergoing a bone marrow or
peripheral blood stem cell transplant presenting with
infectious episodes.9,15,17,18 Some authors have detect-
ed very high IL-6 levels in patients with Gram-nega-
tive bacteremia.5,24,25 We were unable to detect such
differences (data not shown).
In this study, pulmonary disease caused increased
values of IL-6 in plasma, a finding which has not been
previously reported in the literature.
IL-6 is an important component in the regulation
of normal hematopoietic activity. It has positive
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Figure 2. 
A: evolution of IL-6 and IL-8 levels in plasma in a patient who
did not develop fever.
B: evolution of IL-6 and IL-8 levels in plasma in a patient who
did develop fever.
Table 3.  Correlation coefficients between interleukin-6 (IL-
6) and interleukin-8 (IL-8) plasma concentrations and renal
dysfunction evaluated by increased creatinine levels in plas-
ma.
IL-6 (+14) and creatinine (+7) r = 0.28*
IL-6 (+14) and creatinine (+21) r = 0.36°
IL-6 (+21) and creatinine (+28) r = 0.33*
IL-6 (+28) and creatinine (+28) r = 0.50°
IL-8 (-1) and creatinine (+1) r = 0.89°
IL-8 (-1) and creatinine (+21) r = 0.45°
IL-8 (-1) and creatinine (+28) r = 0.53°
IL-8 (-1) and creatinine (+35) r = 0.66°
IL-8 (+21) and creatinine (+28) r = 0.48°
IL-8 (+21) and creatinine (+35) r = 0.42*
*0.05 < p < 0.1; °0.005 < p < 0.05; #p< 0.005.
A
B
effects on thrombopoiesis19 and supports the granu-
locytic differentiation of hematopoietic progenitor
cells.26 In some patients who did not have any febrile
episodes during the transplantation procedure, we
observed IL-6 and IL-8 plasma peaks preceding the
hematologic recovery (as evaluated by an increase in
neutrophil count) as Steffen et al.18 also reported.
We observed a positive correlation between IL-6 or
IL-8 levels and bilirubin or creatinine concentrations.
Similar findings concerning IL-6 and hyperbilirubine-
mia have been reported18 in the literature.  Increased
plasma IL-8 levels on day –1 seemed to predict renal
impairment after transplantation in our patients.
Remberger et al.10 reported high levels of IL-8 in
patients developing VOD. In this study only 3
patients were diagnosed as having VOD and this rela-
tionship could not be confirmed. High IL-8 levels
were, however, found in plasma of  patients with high
bilirubin values, which indicate early liver damage.
TNF-a, IL-1 and IL-6 probably play important roles
in the initiation and progress of GvHD as in other
immunologic reactions, but it is also probable that a
more complex relationship exists between cytokine
production and other biological events in GvHD
which confounds the assignment of exact roles to the
different cytokines. No direct association was seen
between plasma levels of TNF-a, IL-1, IL-6 and IL-8
and acute GvHD in the present study or in others.8,17
It has been suggested that the analysis of cytoplasmic
TNF-a and IL-1 levels in peripheral blood mononu-
clear cells could be a more reliable marker of GvHD
than serum or plasma cytokine concentrations.15
Imamura et al.16 determined the serum levels of
TNF-a, IL-1a, IL-6 and IFN-g in patients receiving a
bone marrow transplant and observed a rise of IL-6,
IFN-g and IL-1a in patients developing GvHD. They
reported that patients receiving an allogeneic trans-
plant had higher TNF-a concentrations than patients
receiving an autologous transplant, probably owing
to a higher incidence of transplant-related compli-
cations with the allogeneic procedure. We found the
same tendency.
We did not find a different pattern of cytokine
secretion depending on the ex vivo manipulation of
the hematopoietic progenitors, although this study
only involved a small number of patients. This result
is in agreement with the similar serum levels of TNF-
a and IL-6 found by Schwaighofer et al.27 in T-cell
depleted and non-T-cell depleted bone marrow
transplants.
The variability of plasma cytokine levels between
patients in the literature may also be related to the
different immunologic assays used. ELISA is a
method that can detect inactive forms of the cytokine
and does not detect in vivo antagonists of the differ-
ent cytokines.28 Moreover, the use of serum or plas-
ma and the sample processing protocol may influ-
ence the results of immunoassays. 
In conclusion, IL-6 and IL-8 were the only cytokines
studied whose increase correlated with infectious
episodes. High IL-8 levels may be a useful predictor
of renal dysfunction and pulmonary disease seems
to trigger off high IL-6 levels in plasma. Plasma TNF-
a and IL-1 concentrations during the post-transplant
period were not shown to be predictive of the devel-
opment of transplant-related complications, and
none of the profiles was recognized to be specific for
a particular complication. 
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